Last Updated: August 3, 2026

Litigation Details for University of Western Australia v. Academisch Ziekenhuis Leiden (D. Del. 2016)


✉ Email this page to a colleague

« Back to Dashboard


University of Western Australia v. Academisch Ziekenhuis Leiden (D. Del. 2016)

Docket 1:16-cv-00109-LPS-CJ Date Filed 2016-02-25
Court District Court, D. Delaware Date Terminated 2016-04-29
Cause 35:0146 Review of Board of Patent Appeals Decision Assigned To Leonard Philip Stark
Jury Demand None Referred To Judge Christopher J. Burke
Patents 8,486,907
Link to Docket External link to docket
Small Molecule Drugs cited in University of Western Australia v. Academisch Ziekenhuis Leiden
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Details for University of Western Australia v. Academisch Ziekenhuis Leiden (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
2016-02-25 1 Interference”) between U.S. Patent No. 8,486,907 (“the UWA ’907 patent”) assigned to Plaintiff University…issued as U.S. Patent No. 7,807,816 (“the UWA ’816 patent”), which is one of the UWA patents involved in…rulings of the Patent Trial and Appeal Board (the “PTAB”) of the United States Patent and Trademark Office…the owner of the UWA ’907 patent. The exclusive licensee of the UWA ’907 patent, Sarepta, has the power…907 patent, as well as the power and right to contest interferences involving the UWA ’907 patent. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Litigation summary and analysis for: University of Western Australia v. Academisch Ziekenhuis Leiden (D. Del. 2016)

Last updated: July 23, 2026

University of Western Australia v. Academisch Ziekenhuis Leiden (1:16-cv-00109-LPS-CJ): Litigation Summary, Procedural Timeline, and IP Risk Analysis

Executive summary: The case University of Western Australia v. Academisch Ziekenhuis Leiden, D.N.J. No. 1:16-cv-00109-LPS-CJ, is a federal patent-related dispute that proceeded through early motion practice but, based on the publicly available docket record referenced in the case caption, the litigation history does not provide enough cited docket outcomes, claim/disposition details, or substantive court holdings to produce an accurate litigation summary with enforceable takeaways (such as what claims survived, what patents were adjudicated, or what the court held on infringement, validity, venue, or injunctive relief).

What claims and patents were at issue in University of Western Australia v. Academisch Ziekenhuis Leiden (1:16-cv-00109-LPS-CJ)?

Answer: Not determinable from the information provided (case caption and docket number only).

Which intellectual property rights did the complaint assert?

The caption-level information does not identify:

  • asserted patent numbers
  • asserted subject matter (composition, method of use, device, process)
  • whether the case involved ownership/inventorship, licensing, interference, or infringement
  • which defendant(s) and which accused acts were pled

What relief was sought?

No accurate identification of requested remedies (damages, accounting, declaratory relief, injunction, specific performance) can be derived from the provided data.


What procedural milestones occurred in D.N.J. 1:16-cv-00109-LPS-CJ?

Answer: Not determinable from the information provided.

Motion practice and claim construction

The docket number alone does not identify:

  • whether there were 12(b)(6), 101/102/103 motions, or Rule 12(c) motions
  • whether any Markman-type proceedings occurred
  • whether discovery was stayed pending related PTO or foreign proceedings

Status indicators for settlement or dismissal

The caption does not reveal whether the matter ended via:

  • settlement and stipulated dismissal
  • consent judgment
  • summary judgment
  • voluntary dismissal under Rule 41
  • dismissal for lack of jurisdiction or failure to prosecute

When did the case begin, and did it reach summary judgment, trial, or settlement?

Answer: Not determinable from the information provided.

Filing and service timeline

The docket number does not provide:

  • the filing date
  • service dates
  • amendment chronology
  • any related petitions (PTAB, ITC, foreign infringement suits)

Trial milestones

No information is available here about:

  • scheduling orders
  • dispositive motion deadlines
  • pretrial filings
  • any trial date or final judgment date

How did the court rule on key issues (jurisdiction, validity, infringement, injunction)?

Answer: Not determinable from the information provided.

Jurisdiction and venue rulings

No information is present about:

  • personal jurisdiction arguments
  • proper venue under 28 U.S.C. § 1400(b)
  • standing or ownership challenges

Patent validity and infringement rulings

No information is present about:

  • § 101 subject matter eligibility determinations
  • anticipation/obviousness outcomes
  • claim construction that drove infringement or noninfringement

Injunction or equitable relief

No information is present about:

  • preliminary injunction motions
  • any assessment under eBay factors
  • any bond requirements

Did Universiy of Western Australia win or lose in University of Western Australia v. Academisch Ziekenhuis Leiden?

Answer: Not determinable from the information provided.

Disposition type

The provided input does not identify whether there was:

  • a final merits judgment
  • a partial disposition
  • a dismissal without prejudice
  • a settlement with a stipulated dismissal

Post-judgment activity

No information is available about:

  • appeals to the Federal Circuit
  • post-judgment motions (Rule 50/59/60)
  • enforcement actions or consent decrees

What does this case mean for biotech and academic patent licensing risk?

Answer: Not determinable from the information provided.

Ownership and licensing disputes

If the case was an ownership or licensing dispute, outcomes can affect:

  • assignment chain certainty
  • diligence obligations for licensees
  • university technology transfer terms But the asserted theory and outcomes are not identifiable from the provided data.

Litigation posture impact

If the case produced noninfringement or invalidity findings, that can affect:

  • portfolio valuation
  • freedom-to-operate strategies
  • patent prosecution and continuation strategy Those results cannot be stated without the docket outcomes.

Key Takeaways

  • No substantiated litigation narrative can be produced from the provided case caption and docket identifier alone.
  • A legally usable summary requires docket-resolved outcomes and/or court orders identifying claims, patents, and holdings, which are not included in the input.

FAQs

  1. What is the docket history for 1:16-cv-00109-LPS-CJ?
  2. Which patents were asserted by University of Western Australia against Academisch Ziekenhuis Leiden?
  3. Was there a Markman order or claim construction ruling in 1:16-cv-00109-LPS-CJ?
  4. Did the court issue a preliminary injunction or deny one in this case?
  5. What was the final disposition of 1:16-cv-00109-LPS-CJ and did either party appeal?

References

  1. U.S. District Court, District of New Jersey. University of Western Australia v. Academisch Ziekenhuis Leiden, No. 1:16-cv-00109-LPS-CJ (case docket).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.